[HTML][HTML] Dopamine receptor subtypes, physiology and pharmacology: new ligands and concepts in schizophrenia

JC Martel, S Gatti McArthur - Frontiers in pharmacology, 2020 - frontiersin.org
Dopamine receptors are widely distributed within the brain where they play critical
modulator roles on motor functions, motivation and drive, as well as cognition. The …

[HTML][HTML] Dopamine and dopamine receptors in Alzheimer's disease: a systematic review and network meta-analysis

X Pan, AC Kaminga, SW Wen, X Wu… - Frontiers in aging …, 2019 - frontiersin.org
Background: The dopaminergic system has been associated with the progression of
Alzheimer's disease. But previous studies found inconsistent results regarding the …

[HTML][HTML] The endocannabinoid system as a target in cancer diseases: are we there yet?

E Moreno, M Cavic, A Krivokuca, V Casadó… - Frontiers in …, 2019 - frontiersin.org
The endocannabinoid system (ECS) has been placed in the anti-cancer spotlight in the last
decade. The immense data load published on its dual role in both tumorigenesis and …

[HTML][HTML] Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?

P Yang, JS Perlmutter, TLS Benzinger, JC Morris… - Ageing research …, 2020 - Elsevier
Parkinson disease (PD) is a neurodegenerative disorder characterized by motor and non-
motor symptoms which relentlessly and progressively lead to substantial disability and …

[HTML][HTML] Neuronal dopamine D3 receptors: translational implications for preclinical research and CNS disorders

B Kiss, I Laszlovszky, B Krámos, A Visegrády, A Bobok… - Biomolecules, 2021 - mdpi.com
Dopamine (DA), as one of the major neurotransmitters in the central nervous system (CNS)
and periphery, exerts its actions through five types of receptors which belong to two major …

Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders

R Juza, K Musilek, E Mezeiova… - Medicinal Research …, 2023 - Wiley Online Library
Dopamine is a biologically active amine synthesized in the central and peripheral nervous
system. This biogenic monoamine acts by activating five types of dopamine receptors (D1 …

[HTML][HTML] The pathophysiology and the therapeutic potential of cannabinoids in prostate cancer

K Singh, N Nassar, A Bachari, E Schanknecht… - Cancers, 2021 - mdpi.com
Simple Summary Prostate cancer, after lung cancer, is the leading cause of death among
men. The incidence rate of prostate cancer varies worldwide between regions and …

Heterobivalent Ligand for the Adenosine A2A–Dopamine D2 Receptor Heteromer

D Pulido, V Casado-Anguera… - Journal of medicinal …, 2022 - ACS Publications
AG protein-coupled receptor heteromer that fulfills the established criteria for its existence in
vivo is the complex between adenosine A2A (A2AR) and dopamine D2 (D2R) receptors …

Synthesis and biological evaluation of fused tricyclic heterocycle piperazine (piperidine) derivatives as potential multireceptor atypical antipsychotics

X Cao, Y Zhang, Y Chen, Y Qiu, M Yu… - Journal of medicinal …, 2018 - ACS Publications
Herein, a novel series of multireceptor ligands was developed as polypharmacological
antipsychotic agents using the designed multiple ligand approach between dopamine …

Rationalizing a prospective coupling effect of cannabinoids with the current pharmacotherapy for melanoma treatment

A Bachari, N Nassar, E Schanknecht… - WIREs Mechanisms …, 2024 - Wiley Online Library
Melanoma is one of the leading fatal forms of cancer, yet from a treatment perspective, we
have minimal control over its reoccurrence and resistance to current pharmacotherapies …